What is it about?
Platelet transfusions consist a major part of the management of hypoplastic thrombocytopenia, the latter occurring mainly among patients with hematological malignancies. They have actually led to a reduction of deaths attributable to thrombocytopenia–induced bleeding, despite their possible complications. This review article sums up their current indications as well as the associated challenges.
Featured Image
Why is it important?
This is a review paper that involves the many medical specialties that take care of patients with malignancy.
Read the Original
This page is a summary of: Hypoplastic thrombocytopenia and platelet transfusion: therapeutic goals, Hospital Practice, November 2018, Taylor & Francis,
DOI: 10.1080/21548331.2019.1546530.
You can read the full text:
Contributors
The following have contributed to this page